← Back to patent-cliff list
CAS 1464999-05-0
4-(5-(bis(2-hydroxyethyl)amino)-2-hydroxy-1-methyl-2,3-dihydro-1H-benzo[d]imidazol-2-yl)butanoic acid
Codes：BENDAM-021
Application context (from source-drug indications)
B-细胞淋巴瘤盐酸苯达莫司汀非霍奇金淋巴瘤盐酸苯达莫司汀慢性淋巴细胞白血病盐酸苯达莫司汀套细胞淋巴瘤盐酸苯达莫司汀淋巴瘤盐酸苯达莫司汀多发性骨髓瘤盐酸苯达莫司汀
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸苯达莫司汀Bendamustine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
dihydro-2H-pyran-2,6(3H)-dione→2,2'-((4-fluoro-3-nitrophenyl)azanediyl)bis(ethan-1-ol)→2,2'-((4-(methylamino)-3-nitrophenyl)azanediyl)bis(ethan-1-ol)→2,2'-((3-amino-4-(methylamino)phenyl)azanediyl)bis(ethan-1-ol)→4-(5-(bis(2-hydroxyethyl)amino)-2-hydroxy-1-methyl-2,3-dihydro-1H-benzo[d]imidazol-2-yl)butanoic acid→methyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.